0001062993-23-016040.txt : 20230808 0001062993-23-016040.hdr.sgml : 20230808 20230808173105 ACCESSION NUMBER: 0001062993-23-016040 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230805 FILED AS OF DATE: 20230808 DATE AS OF CHANGE: 20230808 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kummeth Charles R. CENTRAL INDEX KEY: 0001534980 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-17272 FILM NUMBER: 231152697 MAIL ADDRESS: STREET 1: 425 MARTINGALE ROAD STREET 2: SUITE 1000 CITY: SCHAUMBURG STATE: IL ZIP: 60173-2213 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIO-TECHNE Corp CENTRAL INDEX KEY: 0000842023 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 411427402 STATE OF INCORPORATION: MN FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 614 MCKINLEY PL N E CITY: MINNEAPOLIS STATE: MN ZIP: 55413 BUSINESS PHONE: 6123798854 MAIL ADDRESS: STREET 1: 614 MCKINLEY PLACE NE CITY: MINNEAPOLIS STATE: MN ZIP: 55413 FORMER COMPANY: FORMER CONFORMED NAME: TECHNE CORP /MN/ DATE OF NAME CHANGE: 19920703 4 1 form4.xml STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES X0508 4 2023-08-05 0000842023 BIO-TECHNE Corp TECH 0001534980 Kummeth Charles R. 614 MCKINLEY PLACE NE MINNEAPOLIS MN 55413 1 1 0 0 Chief Executive Officer 0 Common Stock 2023-08-05 4 M 0 51516 0 A 1310282 D Common Stock 2023-08-05 4 F 0 31962 82.17 D 1278320 D Common Stock 400 I By Step-Son Common Stock 400 I By Step-Daughter Stock Options (Right to Buy) 31.2625 2024-08-09 Common Stock 779084 779084 D Stock Options (Right to Buy) 44.33 2025-08-08 Common Stock 361336 361336 D Stock Options (Right to Buy) 44.33 2025-08-08 Common Stock 240888 240888 D Stock Options (Right to Buy) 47.6025 2026-08-07 Common Stock 342900 342900 D Stock Options (Right to Buy) 47.6025 2026-08-07 Common Stock 228600 228600 D Stock Options (Right to Buy) 66.9675 2027-08-05 Common Stock 66600 66600 D Stock Options (Right to Buy) 66.9675 2027-08-05 Common Stock 299768 299768 D Restricted Stock Units 2023-08-05 4 M 0 51516 0 D Common Stock 51516 0 D Restricted Stock Units Common Stock 52900 52900 D Stock Options (Right to Buy) 66.9675 2027-08-05 Common Stock 153180 153180 D Restricted Stock Units Common Stock 32064 32064 D Stock Options (Right to Buy) 120.455 2028-08-06 Common Stock 125260 125260 D Stock Options (Right to Buy) 120.455 2028-08-06 Common Stock 83504 83504 D Stock Options (Right to Buy) 94.52 2029-08-15 Common Stock 600000 600000 D Includes 7,128 shares of restricted stock for which the risk of forfeiture will lapse on August 6, 2024. Fully exercisable. Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. On 8/5/2023, the Board of Directors certified vesting of 51,516 performance RSUs. 17,632 shares vest on each of 8/15/2023 and 8/15/2025, and 17,636 shares vest on 8/15/2024. Options to purchase 38,292 shares vest on 8/5/21 and options to purchase 38,296 shares vest on each of 8/5/22, 8/5/23 and 8/5/24. Vests in full or in part on 8/6/2024 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). Options to purchase 20,876 shares vest on each of 8/6/2022, 8/6/2023, 8/6/2024 and 8/6/2025. 600,000 options vest in full or in part on 7/1/2024 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). /s/ Andrew Nick, as Attorney-in-Fact pursuant to Power of Attorney previously filed. 2023-08-08